(Q83512698)
Statements
Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B (English)
Jens M Kittner
Martin F Sprinzl
Annette Grambihler
Peter R Galle
Marcus Schuchmann
24 February 2012